| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/15/1998 | EP0853084A2 Substituted purine derivatives as vitronectin receptor antagonists |
| 07/15/1998 | EP0853083A1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof |
| 07/15/1998 | EP0852587A2 Synthetic peptides that inhibit il-6 activity |
| 07/15/1998 | EP0852504A1 Inhibitors of integrin receptors and their therapeutical uses |
| 07/15/1998 | EP0646119B1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque |
| 07/15/1998 | CN1187490A 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 07/15/1998 | CN1187361A Plaster for curing arthralgia-syndrome |
| 07/15/1998 | CN1187350A Analgesic for osteonosus and osteoarthropathy |
| 07/14/1998 | US5780508 Pharmacological preparations comprising a cystine derivative |
| 07/14/1998 | US5780467 Morpholine compounds are prodrugs useful as tachykinin receptor antagonists |
| 07/14/1998 | US5780455 Nonsettling acidic isotonic aqueous solution comprising sodium citrate, citric acid and sodium chloride |
| 07/14/1998 | US5780454 Boronic ester and acid compounds |
| 07/14/1998 | US5780064 Germicidal compositions for the treatment of animal infectious diseases of the hoof |
| 07/09/1998 | WO1998029447A1 Novel human apoptosis regulator |
| 07/09/1998 | WO1998029430A1 G-rich oligo aptamers and methods of modulating an immune response |
| 07/09/1998 | CA2278340A1 Novel human apoptosis regulator |
| 07/09/1998 | CA2278031A1 G-rich oligo aptamers and methods of modulating an immune response |
| 07/08/1998 | EP0851760A1 Interleukin converting enzyme and apoptosis |
| 07/08/1998 | CN1186671A External use liniment for rheumatism made of natural plant material |
| 07/08/1998 | CN1039012C Novel phospholipid derivatives |
| 07/07/1998 | US5776977 Arylcycloalkyl derivatives, their production and their use |
| 07/07/1998 | US5776193 Biodegradable bone replacement comprising network of mineralized biopolymer fibers and binder |
| 07/02/1998 | WO1998028423A2 Compositions and methods of use for osteoclast inhibitory factors |
| 07/02/1998 | WO1998028324A1 Steroids substituted in position 11, method of preparation, application as medicines and pharmaceutical compositions containing them |
| 07/02/1998 | WO1998028301A1 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 07/02/1998 | WO1998028292A1 Novel piperidine containing compounds |
| 07/02/1998 | WO1998028264A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 07/02/1998 | WO1998027987A1 New treatment for joint inflammation |
| 07/02/1998 | WO1998027976A1 Prevention and treatment of skeletal disorder with ep2 receptor subtype selective prostaglandin e2 agonists |
| 07/02/1998 | WO1998027965A1 Pharmaceutical composition with base of rhein or diacerhein with improved biological availability |
| 07/02/1998 | CA2275955A1 Steroids substituted in position 11, method of preparation, application as medicines and pharmaceutical compositions containing them |
| 07/02/1998 | CA2275312A1 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 07/02/1998 | CA2274769A1 New treatment for joint inflammation |
| 07/01/1998 | EP0850647A1 Application of 11-substituted steroids for the preparation of medicaments with dissociated estrogenic activity |
| 07/01/1998 | EP0850068A1 Lipid extract having anti-inflammatory activity |
| 07/01/1998 | EP0850055A2 Protein tyrosine kinase inhibitors for treating osteoarthritis |
| 07/01/1998 | CN1186501A Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
| 07/01/1998 | CN1186438A Methods and compositions for healing and repair of connective tissue attachment |
| 06/30/1998 | US5773646 Integrin inhibitors |
| 06/30/1998 | US5773570 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 06/30/1998 | US5773530 Pyrazolopyridine adenosine antagonists |
| 06/30/1998 | US5773477 Combination therapy to treat osteoporosis - polyphosphonates and estrogen agonists |
| 06/30/1998 | US5773465 Tartronic acids, their acetalic ethers and o-esters |
| 06/25/1998 | WO1998027202A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses |
| 06/25/1998 | WO1998027108A2 New amide compounds and their use as nitric oxide synthase inhibitors |
| 06/25/1998 | WO1998027098A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 06/25/1998 | WO1998027069A1 Piperazine compounds as inhibitors of mmp or tnf |
| 06/25/1998 | WO1998019649A3 Methods and compositions for inhibition of angiogenesis |
| 06/25/1998 | WO1998016504A3 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
| 06/25/1998 | WO1998002151A3 Chemokine receptor antagonists and methods of use therefor |
| 06/25/1998 | CA2275478A1 Piperazine compounds as inhibitors of mmp or tnf |
| 06/25/1998 | CA2274807A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses |
| 06/24/1998 | CN1185338A 胶原蛋白口服制剂及制备方法 Collagen oral formulation and preparation methods |
| 06/23/1998 | US5770586 Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism amd methods of treating and preventing dental calculus and plaque |
| 06/23/1998 | US5770571 Method and agents for inhibiting protein aging |
| 06/23/1998 | US5770226 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
| 06/23/1998 | US5770196 Modified antibody variable domains and therapeutic uses thereof |
| 06/23/1998 | CA2056384C Bioerodible polymers for drug delivery in bone |
| 06/20/1998 | CA2225273A1 Vitronectin receptor antagonists, their preparation and their use |
| 06/20/1998 | CA2225267A1 Vitronectin receptor antagonists, their preparation and their use |
| 06/18/1998 | WO1998026070A1 Bone stimulating factor |
| 06/18/1998 | WO1998026069A1 Methods and compositions for identifying morphogen analogs |
| 06/18/1998 | WO1998026068A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | WO1998026047A1 Methods and compositions for identifying morphogen analogs |
| 06/18/1998 | WO1998025971A1 Monovalent antibody fragments |
| 06/18/1998 | WO1998025627A1 17α-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT |
| 06/18/1998 | WO1998025626A1 Use of equilenin as an antioxidant |
| 06/18/1998 | WO1998025625A1 USE OF 17β-DIHYDROEQUILENIN AS AN ANTIOXIDANT |
| 06/18/1998 | WO1998025619A1 Novel compounds |
| 06/18/1998 | WO1998025609A1 PYRROLES AS sPLA2 INHIBITORS |
| 06/18/1998 | WO1998025469A1 The use of cd4-binding small molecules to inhibit immune responses |
| 06/18/1998 | WO1998025460A1 Compositions and methods for stimulating bone growth |
| 06/18/1998 | WO1998015568A3 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 06/18/1998 | CA2274789A1 Compositions and methods for stimulating bone growth |
| 06/18/1998 | CA2274739A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | CA2274655A1 Novel compounds |
| 06/18/1998 | CA2274604A1 The use of cd4-binding small molecules to inhibit immune responses |
| 06/18/1998 | CA2274571A1 Pyrroles as spla2 inhibitors |
| 06/18/1998 | CA2274500A1 Bone stimulating factor |
| 06/18/1998 | CA2272089A1 17.alpha.-dihydroequilenin for use as a medical antioxidant |
| 06/18/1998 | CA2272087A1 Use of equilenin as an antioxidant |
| 06/18/1998 | CA2272074A1 Use of 17.beta.-dihydroequilenin as an antioxidant |
| 06/17/1998 | EP0847278A1 Analogs of parathyroid hormone |
| 06/17/1998 | EP0448704B1 Osteogenic devices |
| 06/17/1998 | CN1185109A Use of vitamin D2 or vitamin D4 derivatives for mfg. medicament for treating secondary hyperparathyroidism |
| 06/17/1998 | CN1184668A Magistral medicine for treating bone disease such as osteoporosis, and method for preparing same |
| 06/17/1998 | CN1184661A Chinese patent drug for treating effevctively old and feeble type disease |
| 06/17/1998 | CN1038751C Cyclopeptides |
| 06/16/1998 | US5767111 18-nor-vitamin D compounds |
| 06/16/1998 | US5766886 Modified antibody variable domains |
| 06/16/1998 | CA2162470C Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance |
| 06/11/1998 | WO1998024922A1 Insulin-like growth factor i (igf-i) expression system and methods of use |
| 06/11/1998 | WO1998024905A2 Secreted proteins and polynucleotides encoding them |
| 06/11/1998 | WO1998024902A1 Adaptor protein frs2 and related products and methods |
| 06/11/1998 | WO1998024805A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/11/1998 | WO1998024804A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/11/1998 | WO1998024782A2 Substituted pyrimidine compounds and their use |
| 06/11/1998 | WO1998024780A2 Substituted pyrimidinone and pyridinone compounds and their use |
| 06/11/1998 | WO1998024766A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 06/11/1998 | WO1998024763A2 Immunotherapeutic imides/amides as pde iv and tnf inhibitors |